Prevention of early onset group B streptococcal disease: controversial issues

Chryssoula Tzialla; Alessandro Borghesi; Francesca Garofoli; Lina Bollani; Stefania Longo; Mauro Stronati

doi:10.1080/14767050903211521

Prevention of early onset group B streptococcal disease: controversial issues

J Matern Fetal Neonatal Med. 2009:22 Suppl 3:38-42. doi: 10.1080/14767050903211521.

Authors

Chryssoula Tzialla¹, Alessandro Borghesi, Francesca Garofoli, Lina Bollani, Stefania Longo, Mauro Stronati

Affiliation

¹ Neonatologia, Patologia Neonatale e Terapia Intensiva, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy.

PMID: 19718586
DOI: 10.1080/14767050903211521

Abstract

Intrapartum chemoprophylaxis is currently the most effective preventive strategy against the neonatal early-onset group B streptococcal infection. The principal controversies on strategies for intrapartum antibiotic administration, possible adverse effects, management of newborn and possible future preventive strategies reported in the literature are considered.

Publication types

Review

MeSH terms

Antibiotic Prophylaxis*
Carrier State / diagnosis*
Carrier State / microbiology
Contraindications
Female
Humans
Infant, Newborn
Infectious Disease Transmission, Vertical / prevention & control*
Mass Screening / methods
Postnatal Care
Pregnancy
Pregnancy Complications, Infectious / prevention & control
Prenatal Care*
Streptococcal Infections / diagnosis
Streptococcal Infections / prevention & control*
Streptococcus agalactiae*